Can persistent circulating immune complexes drive chronic systemic inflammation and pain sensitization?

Persistent circulating immune complexes (ICs) act as potent triggers for chronic inflammatory states by simultaneously engaging the complement cascade and Fc-gamma receptors (FcγRs). This dual activation establishes a self-reinforcing loop of cytokine production that can drive systemic inflammation and lower pain thresholds.

Mechanistic evidence

The activation of these pathways by immune complexes is a well-characterized biological process:

• Complement Activation: Immune complexes, formed by the binding of antigens and antibodies (IgG or IgM), initiate the classical complement pathway when the C1q protein binds to the antibody's Fc region. This cascade generates anaphylatoxins, particularly C5a, which are powerful recruitment signals for inflammatory cells.
• Fc Receptor Signaling: Simultaneously, ICs cross-link FcγRs on the surface of immune cells like macrophages and neutrophils. This cross-linking activates intracellular signaling via the Syk and PLCγ2 pathways, leading to the nuclear translocation of NF-κB and the transcription of pro-inflammatory genes.
• Synergistic Feedback: Research highlights a "mutual reinforcement" between these systems. Specifically, C5a binding to its receptor (C5aR) upregulates the expression of activating FcγRs while downregulating inhibitory receptors (FcγRIIB). This shift significantly lowers the threshold for cellular activation, allowing even low levels of circulating complexes to maintain a high-inflammatory state.

Clinical and effectiveness evidence

The persistence of these mechanisms has direct implications for systemic health and pain:

• Sustained Cytokine Release: The synergy between C5aR and FcγR signaling results in the chronic secretion of key cytokines, including TNF-α, IL-1β, and IL-6. Clinical data from autoimmune conditions like lupus and rheumatoid arthritis demonstrate that elevated IC levels correlate directly with markers of systemic inflammation and complement consumption.
• Pain Sensitization: Sustained levels of circulating cytokines promote both peripheral and central pain sensitization. For example, TNF-α and IL-1β increase the excitability of spinal dorsal horn neurons by upregulating NMDA receptor activity.
• Neuroimmune Interaction: Systemic cytokines can activate microglia in the central nervous system, shifting them to a pro-inflammatory phenotype. This glial activation further releases mediators like IL-18 and CGRP, which maintain neuronal hyperactivity and contribute to chronic pain states.

Bottom line

Persistent circulating immune complexes drive a bidirectional feedback loop between the complement system and Fc receptors. This synergy prevents the resolution of inflammation, leads to chronic cytokine release, and promotes pain sensitization through increased synaptic excitability and glial activation.